December 09, 2016 BY Valentina Kirilova

LSE welcomes Creo Medical Group’s AIM IPO

London Stock Exchange welcomed the AIM flotation of Creo Medical Group, a medical device company focused on the emerging field of surgical endoscopy. The Chepstow-based company raised £20 million on admission, with a market capitalisation of approximately £61 million. The company has been supported by Finance Wales, who have an equity stake in the company. The…

Read more